SkinVision is an AI-powered mobile application designed to support early detection of skin cancer. By using a smartphone camera, users can take photos of suspicious moles or skin spots and receive a risk assessment within minutes. The app’s clinically validated algorithm analyzes the image to determine whether a lesion is low, medium, or high risk, helping users decide if they should consult a healthcare professional.
Founded with the mission to make skin health monitoring accessible and proactive, SkinVision empowers users to take control of their dermatological wellbeing without needing immediate access to a specialist. The platform has been used by millions of people and has helped detect thousands of cases of skin cancer early.
SkinVision is a certified Class I medical device in the European Union and is available in multiple countries. It is backed by clinical studies and partnerships with dermatologists, researchers, and healthcare providers.
Features
SkinVision’s core feature is its AI-based skin risk assessment. Users take a clear, close-up photo of a skin lesion using their smartphone. The app’s algorithm then analyzes the image and returns a result categorized as low, medium, or high risk.
The app includes a photo storage and tracking system, enabling users to monitor changes in their skin over time. This feature is particularly useful for spotting evolving moles or new lesions, which are critical indicators of potential skin cancers.
SkinVision also offers educational resources on skin health, providing guidance on what to look for in skin changes, how to identify warning signs, and when to seek professional medical help.
Users can also share results with a dermatologist or healthcare provider directly from the app, supporting more informed consultations and better continuity of care.
The app supports multiple languages and includes reminders and notifications for users to perform regular checks, promoting preventive habits.
How It Works
To use SkinVision, users download the app and create a profile. They then use their smartphone camera to take a well-lit, focused photo of a mole or skin spot they want assessed.
The photo is uploaded to SkinVision’s secure platform, where it is analyzed using a machine learning algorithm trained on over 4 million skin images. Within about 30 seconds, the app returns a risk assessment indicating whether the lesion is low, medium, or high risk.
If the result is high risk, the app advises the user to consult a healthcare professional for further examination. The image and result can be downloaded or shared digitally with a provider.
For users monitoring multiple spots or existing moles, the app stores each image with a date stamp, enabling easy comparison over time.
The platform does not offer diagnosis or treatment but serves as a triage and awareness tool to catch potential issues early.
Use Cases
SkinVision is widely used by individuals who want to monitor their skin at home, especially those with a history of skin cancer or increased risk due to factors like fair skin, frequent sun exposure, or family history.
People in rural or underserved areas use the app to assess lesions without immediate access to dermatologists, reducing delays in detection.
Parents use the app to monitor their children’s moles or new skin growths, while travelers use it to check skin concerns when abroad.
Healthcare providers recommend SkinVision to patients as a self-monitoring tool between dermatology visits, enhancing patient engagement and awareness.
Employers and insurers also promote SkinVision as part of preventive health initiatives, aiming to reduce late-stage cancer diagnoses and associated treatment costs.
Pricing
SkinVision offers both free and paid versions of its service.
The free version provides access to educational content, basic skin checks, and the ability to track skin spots over time.
The premium version, which includes full access to unlimited AI skin checks and professional review for high-risk results, is offered via subscription:
Monthly subscription: Approximately €6.99/month
Yearly subscription: Approximately €24.99/year
One-time skin check: Around €4.99 per check
Prices may vary slightly by region or currency. Organizations such as insurers or employers may offer SkinVision access as a sponsored health benefit.
Strengths
One of SkinVision’s biggest strengths is its clinical validation, with multiple peer-reviewed studies demonstrating the accuracy of its AI algorithm in identifying high-risk lesions.
The ease of use and smartphone accessibility make it practical for the general public, requiring no medical background or equipment.
Its quick turnaround time for assessments (less than a minute) provides users with peace of mind or early warnings without long wait times.
SkinVision’s photo tracking system supports long-term skin health monitoring, and the ability to export and share results with a physician streamlines follow-up care.
The app has received CE marking as a Class I medical device, and its algorithm is continuously updated based on new data and dermatological insights.
Drawbacks
SkinVision does not provide a medical diagnosis, which means users must still consult a healthcare provider if a lesion is marked high risk.
The accuracy of the result depends on image quality, so users must carefully follow instructions to take a proper photo in good lighting and focus.
SkinVision may not detect every skin cancer type, especially non-visible or sub-dermal lesions that require in-person examination or biopsy.
There is a cost associated with full access, which may deter some users, although the annual pricing remains affordable compared to in-clinic screenings.
Some regions may have limited access or language support, although the platform continues to expand internationally.
Comparison with Other Tools
SkinVision is often compared with other mobile dermatology tools like Miiskin, FirstDerm, and MoleScope.
Compared to Miiskin, which focuses on mole tracking and skin logging without risk assessment, SkinVision provides real-time AI-based risk analysis, making it more actionable.
FirstDerm allows users to submit photos to a dermatologist for review, while SkinVision offers immediate feedback via AI, with optional follow-up guidance for high-risk cases.
MoleScope provides dermatoscopic imaging for professionals, whereas SkinVision is aimed at consumer-level accessibility and ease of use with no extra equipment required.
SkinVision’s balance of AI analysis, affordability, and ease of use makes it a strong tool for early skin cancer detection, especially for those without regular dermatologist access.
Customer Reviews and Testimonials
Users praise SkinVision for its simplicity, speed, and peace of mind. Many report that the app prompted them to seek medical advice earlier than they otherwise would have, with some users confirming that suspicious lesions identified by the app were later diagnosed as skin cancers by dermatologists.
Clinicians recognize the platform’s role in raising awareness and supporting early triage, although they emphasize that it is not a replacement for professional care.
Organizations that have adopted SkinVision in preventive programs report improved engagement in skin health and positive feedback from employees and members.
SkinVision has been featured in publications such as The Guardian, Forbes, and Wired, and is recognized as one of the pioneers in mobile AI health applications.
Conclusion
SkinVision offers a powerful and accessible way for people to monitor their skin health and detect possible signs of skin cancer early. With its AI-driven technology, simple user experience, and clinically validated results, it supports proactive care and early intervention—critical factors in reducing the impact of skin cancer.
Whether used individually or as part of a healthcare or workplace wellness program, SkinVision serves as a valuable digital companion in the journey toward better skin health.
